All In MedTech

Device Trial Radar · NCT07485075

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

SBI 2024-2026 STENO FOOD CONCEPT

Last checked: Nov 20, 2026Latest source record: Mar 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

104

Planned (sponsor's estimate)

Start

Mar 20, 2026

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Steno Diabetes Center CopenhagenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 20, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).

Conditions

  • Diabetes Type 2
  • Kidney Disease

Interventions

  • StenoFood AppDevice

    Digital patient education program (app-based) with dietary guidance and self-monitoring tools

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in sodium excretion between measurements at baseline and 6 months follow-upTime frame: 6 month

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Steno Diabetes Center Copenhagen,

    Herlev, Captial Region of Denmark, Denmark · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.